Japan· JP-6343439G1027
pH4処理酸性人免疫グロブリン(皮下注射)
A medicinal product containing ph4処理酸性人免疫グロブリン(皮下注射), registered in Japan by CSLベーリング, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- pH4処理酸性人免疫グロブリン(皮下注射)
- Manufacturer
- CSLベーリング
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ph4処理酸性人免疫グロブリン(皮下注射) in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumCutaquig 165 mg/mlOctapharma Benelux
- United StatesAlygloGC Biopharma Corp.
- SpainBERIGLOBINA PCsl Behring S.A.
- FinlandCutaquigOctapharma AB
- SwedenBeriglobin 160 mg/ml Injektionsvätska, lösning i förfylld sprutaCSL Behring GmbH
- CzechiaGAMMANORMOctapharma (IP) SPRL, Brusel
- GermanyBeriglobinCsl Behring Gmbh
- IcelandCutaquigOctapharma AB
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Cutaquig, Cuvitru
- Belgium · Cutaquig, Cuvitru
- Bulgaria · Имуновенин, Интратект
- Cyprus · Gamunex, Intratect
- Czechia · Cutaquig, Cuvitru
- Germany · Beriglobin, Cutaquig
- Denmark · Cutaquig, Cuvitru
- Estonia · Cutaquig, Gammanorm
- Spain · Cutaquig, Cuvitru
- Finland · Cutaquig, Cuvitru
- France · Clairyg, Cutaquig
- United Kingdom (Northern Ireland) · Cutaquig, Cuvitru
- Greece · Gaminex, Ig Vena
- Croatia · Cutaquig, Ig Vena
- Hungary · Cutaquig, Gammanorm
- Ireland · Cutaquig, Cuvitru
- Iceland · Cutaquig, Deqsiga
- Italy · Cutaquig, Cuvitru
- Liechtenstein · Deqsiga, Flebogamma Dif
- Lithuania · Cutaquig, Gammanorm
- Luxembourg · Cutaquig, Gammagard S/D (Solvent/Detergent)
- Latvia · Cutaquig, Gammanorm
- Malta · Cutaquig, Gammanorm
- Netherlands · Cutaquig, Cuvitru
- Norway · Cutaquig, Cuvitru
- Poland · Cutaquig, Cuvitru
- Portugal · Cutaquig, Gammanorm
- Romania · Cutaquig, Gammanorm
- Sweden · Cutaquig, Cuvitru
- Slovenia · Cutaquig, Gammanorm
- Slovakia · Cutaquig, Cuvitru
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e5e1aa6a-3e68-4362-b075-26b20a221d3a GET /v1/drugs/e5e1aa6a-3e68-4362-b075-26b20a221d3a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "1g5mL1筒",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "6343439G1027",
"category": "注射薬",
"price_yen": 13485,
"generic_name": "pH4処理酸性人免疫グロブリン(皮下注射)",
"product_name_jp": null,
"therapeutic_class": "6343",
"transitional_expiry": null
}See everything about ph4処理酸性人免疫グロブリン(皮下注射).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.